(Q40441543)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605850%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

review article

1 reference

title

Review article: functional dyspepsia--should treatment be targeted on disturbed physiology? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605850%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Review article: functional dyspepsia—should treatment be targeted on disturbed physiology? (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

10 June 2024

1 reference

N. J. Talley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605850

10 June 2024

language of work or name

English

0 references

publication date

1 April 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605850%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.1995.tb00359.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2036.1995.tb00359.x

10 June 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Alimentary Pharmacology & Therapeutics

10 June 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605850%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605850%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605850%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

107-115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605850%20AND%20SRC:MED&resulttype=core&format=json

Symptoms in gastro-oesophageal reflux disease

21 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Non-ulcer dyspepsia: potential causes and pathophysiology

10 June 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis

10 June 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride

10 June 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients

10 June 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Manometric evaluation of functional upper gut symptoms.

10 June 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Gastric and autonomic responses to stress in functional dyspepsia

10 June 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Electrogastrographic study of gastric myoelectrical activity in patients with unexplained nausea and vomiting

10 June 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Management of dyspepsia: report of a working party

10 June 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study

10 June 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia

10 June 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone

10 June 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Basic and clinical aspects of visceral hyperalgesia

10 June 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial

10 June 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.

10 June 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

The current role of erythromycin in the clinical management of gastric emptying disorders

10 June 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies

10 June 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Effect of misoprostol on postprandial intestinal motility and orocecal transit time in humans

10 June 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Misoprostol treatment exacerbates abdominal discomfort in patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled, multicentre study

10 June 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders

10 June 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.

10 June 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone

10 June 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

A somatostatin analogue inhibits afferent pathways mediating perception of rectal distention.

10 June 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Effect of CCK and its antagonists on gastric emptying

10 June 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Effect of trimebutine maleate on emptying of stomach and gallbladder and release of gut peptide following a solid meal in man.

10 June 2024

44

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Trimebutine, a new antispasmodic in the treatment of dyspepsia

10 June 2024

45

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Effect of glyceryl trinitrate on antral motility and symptoms in patients with functional dyspepsia.

10 June 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications

10 June 2024

49

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Effect of oral nicardipine on anorectal function in normal human volunteers and patients with irritable bowel syndrome

10 June 2024

52

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Comparison of dicyclomine with antacid and without antacid in dyspepsia

10 June 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Dicyclomine for idiopathic dyspepsia

10 June 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Efficacy of leuprolide in treatment of the irritable bowel syndrome

10 June 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study

10 June 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Effect of leuprolide acetate in patients with functional bowel disease. Long-term follow-up after double-blind, placebo-controlled study

10 June 2024

57

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Helicobacter pylori and luminal gastric pH. Relationships in nonulcer dyspepsia

10 June 2024

58

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia

10 June 2024

59

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects

10 June 2024

60

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia.

10 June 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia.

10 June 2024

63

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Relationship between Gastric Inflammatory Response and Symptoms in Patients Infected withHelicobacter pylori

10 June 2024

64

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Is gastroduodenitis a cause of chronic dyspepsia?

10 June 2024

65

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia

10 June 2024

67

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Is there an abnormal fasting duodenogastric reflux in nonulcer dyspepsia?

10 June 2024

69

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Sucralfate in clinical practice

10 June 2024

70

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Efficacy of sucralfate in treatment of non-ulcer dyspepsia. A double-blind placebo-controlled study

10 June 2024

71

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Controlled clinical trial with sucralfate in the treatment of macroscopic gastritis

10 June 2024

72

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Sucralfate versus placebo in treatment of non-ulcer dyspepsia

10 June 2024

73

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori

10 June 2024

74

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Campylobacter pylori--a role in non-ulcer dyspepsia?

10 June 2024

75

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study

10 June 2024

76

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Helicobacter pyloriInfection and Non-Ulcer Dyspepsia: The Effect of Treatment with Colloidal Bismuth Subcitrate

10 June 2024

77

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate

10 June 2024

78

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Central serotonin receptors and delayed gastric emptying in non-ulcer dyspepsia

10 June 2024

79

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

A controlled trial of psychological treatment for the irritable bowel syndrome

10 June 2024

80

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Cognitive therapy for irritable bowel syndrome

10 June 2024

81

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

The irritable bowel syndrome: review and a graduated multicomponent treatment approach

10 June 2024

82

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients

10 June 2024

83

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

The clinical pharmacology of motility disorders: the perils (and pearls) of prokinesia

10 June 2024

84

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00359.X

10 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605850%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference